Literature DB >> 12559964

P27 knockout mice: reduced myostatin in muscle and altered adipogenesis.

Ji Lin1, Mary Anne Della-Fera, Changlong Li, Karen Page, Yang Ho Choi, Diane L Hartzell, Clifton A Baile.   

Abstract

Knockout of the P27(kip) gene, which encodes a cyclin-dependent kinase inhibitor involved in cell proliferation regulation, results in growth enhancement in mice. To investigate how p27 deficiency affected adipogenesis and myogenesis, levels of PPARgamma, C/EBPalpha, and the myogenesis inhibitor, myostatin, were measured in p27(-/-) (n=14), p27(+/-) (n=18), and p27(+/+) mice (n=11). Body weight and gastrocnemius muscle (GC) mass were increased in p27(-/-) mice (P<0.05), but there were no differences in fat depot weights, percent body fat or serum leptin concentrations among genotypes. PPARgamma, but not C/EBPalpha, was markedly increased in p27(-/-) mice (P<0.05). There was also a higher incidence of inguinal fat apoptosis (P<0.01) in p27(-/-) mice. Myostatin levels were reduced in GC muscle of p27(-/-) mice (P<0.05). These findings suggest that in p27 deficient mice, increased skeletal muscle mass is mediated in part through decreased myostatin. Although total adiposity was not changed, increased PPARgamma levels suggest an alteration in adipogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559964     DOI: 10.1016/s0006-291x(02)02949-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Karyopherin Alpha 1 Regulates Satellite Cell Proliferation and Survival by Modulating Nuclear Import.

Authors:  Hyo-Jung Choo; Alicia Cutler; Franziska Rother; Michael Bader; Grace K Pavlath
Journal:  Stem Cells       Date:  2016-08-01       Impact factor: 6.277

Review 2.  Aging of signal transduction pathways, and pathology.

Authors:  Morgan E Carlson; Haroldo S Silva; Irina M Conboy
Journal:  Exp Cell Res       Date:  2008-04-07       Impact factor: 3.905

Review 3.  Two-way communication between the metabolic and cell cycle machineries: the molecular basis.

Authors:  Joanna Kaplon; Loes van Dam; Daniel Peeper
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis.

Authors:  You-you Zhang; Xi Li; Shu-wen Qian; Liang Guo; Hai-yan Huang; Qun He; Yuan Liu; Chun-gu Ma; Qi-Qun Tang
Journal:  Mol Endocrinol       Date:  2012-03-15

Review 5.  Role of cell cycle regulators in adipose tissue and whole body energy homeostasis.

Authors:  I C Lopez-Mejia; J Castillo-Armengol; S Lagarrigue; L Fajas
Journal:  Cell Mol Life Sci       Date:  2017-10-07       Impact factor: 9.261

6.  Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet.

Authors:  Yuan-Hung Lo; Po-Chun Ho; Min-Shan Chen; Eric Hugo; Nira Ben-Jonathan; Shao-Chun Wang
Journal:  Biochem Biophys Res Commun       Date:  2012-11-28       Impact factor: 3.575

7.  Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells.

Authors:  Morgan E Carlson; Michael Hsu; Irina M Conboy
Journal:  Nature       Date:  2008-06-15       Impact factor: 49.962

Review 8.  Cycling through metabolism.

Authors:  Victor Aguilar; Lluis Fajas
Journal:  EMBO Mol Med       Date:  2010-09       Impact factor: 12.137

9.  Regulation of p27 and Cdk2 Expression in Different Adipose Tissue Depots in Aging and Obesity.

Authors:  Ignacio Colón-Mesa; Marta Fernández-Galilea; Neira Sáinz; Marta Lopez-Yus; Jose M Artigas; José Miguel Arbonés-Mainar; Elisa Félix-Soriano; Xavier Escoté; María Jesús Moreno-Aliaga
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

10.  A Novel Dnmt3a1 Transcript Inhibits Adipogenesis.

Authors:  Bahareldin A Abdalla; Zhenhui Li; Hongjia Ouyang; Endashaw Jebessa; Tianhao Sun; Jia-Ao Yu; Bolin Cai; Biao Chen; Qinghua Nie; Xiquan Zhang
Journal:  Front Physiol       Date:  2018-10-02       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.